The «» query returned 3 matches.

Sorted by relevancedate

  1. SIBUR TO LAUNCH LATEX PRODUCTION

    By the end of 2020, SIBUR’s Krasnoyarsk site plans to start commercial production of synthetic nitrile butadiene rubber (NBR) latex with an annual capacity of 3.5 kt. By the end of 2020, SIBUR’s Krasnoyarsk site plans to start commercial production of synthetic nitrile butadiene rubber (NBR) latex with an annual capacity of 3.5 kt. The project aims to develop a feedstock base for import substitution of technical and diagnostic exam (including medical) gloves through localisation of production in...

  2. COVID-19: HUMANITY VS VIRUS

    ... extensively adopted. We conducted our own poll regarding the potential of the existing antiviral drugs to prevent COVID-19, and found out why medications stimulating immunity are so controversial. Battlefield: immunomodulators “These is no medicine that can prevent a disease caused by the coronavirus infection. There are no ways to prevent or treat COVID-19. Therefore, there is not much point in buying antiviral medications. Immunomodulators – even Oxolinum ointment – have no positive ...

  3. Plastic in medicine

    ... materials were produced in the 19th century, but it was not until the middle of the 20th century that the advances in production technology helped plastic make its way into the healthcare industry. The use of plastic has revolutionised the field of medicine. Previously, medical devices were made of glass, metals or ceramics and had to be boiled, heated (autoclaved) or otherwise disinfected before every use. This was a long and painstaking process and its outcome was hard to control (today, surgical ...